CRISPR-Cas系统的小型化研究进展

董颖; 马孟丹; 黄卫人

doi:10.12211/2096-8280.2023-068

您当前的位置：

首页 >

文章列表页 >

CRISPR-Cas系统的小型化研究进展

特约评述 | 更新时间：2025-06-20

- CRISPR-Cas系统的小型化研究进展
- Progress in the miniaturization of CRISPR-Cas systems
- 合成生物学 2025年6卷第1期页码：105-117
- 作者机构：
  
  1.深圳大学第一附属医院泌尿外科，国家地方联合肿瘤基因组临床应用关键技术工程实验室，广东深圳 518036
  2.中国科学院深圳先进技术研究院合成生物学研究所，广东深圳 518000
- 作者简介：
  
  [ "董颖（1998—），女，硕士研究生。研究方向为医学合成生物学。 E-mail：dongyingdcc@163.com" ]
  [ "马孟丹（1997—），女，博士研究生。研究方向为医学合成生物学。 E-mail：mamengdan7@163.com" ]
  [ "黄卫人（1980—），男，研究员，博士生导师。研究方向为肿瘤合成生物学，肿瘤类器官培养及精准医学。 E-mail：pony8980@163.com" ]
- 基金信息：
- DOI：10.12211/2096-8280.2023-068
  中图分类号： Q816
- 收稿：2023-09-21，
  
  修回：2024-03-21，
  
  纸质出版：2025-01-31
- 稿件说明：
移动端阅览
董颖，马孟丹，黄卫人. CRISPR-Cas系统的小型化研究进展［J］. 合成生物学， 2025， 6（1）： 105-117

DONG Ying， MA Mengdan， HUANG Weiren. Progress in the miniaturization of CRISPR-Cas systems［J］. Synthetic Biology Journal， 2025， 6（1）： 105-117
董颖，马孟丹，黄卫人. CRISPR-Cas系统的小型化研究进展［J］. 合成生物学， 2025， 6（1）： 105-117 DOI： 10.12211/2096-8280.2023-068.

DONG Ying， MA Mengdan， HUANG Weiren. Progress in the miniaturization of CRISPR-Cas systems［J］. Synthetic Biology Journal， 2025， 6（1）： 105-117 DOI： 10.12211/2096-8280.2023-068.

摘要

CRISPR-Cas基因编辑技术由于其简便性和高效性，已被广泛应用于生物学、医学、农学等领域的基础与应用研究。目前广泛使用的Cas核酸酶均具有较大的分子量（通常大于1000个氨基酸），而广泛应用于基因治疗中的腺相关病毒（AAV）载体的承载容量却十分有限，在容纳CRISPR核酸酶与gRNA的编码序列之余往往难以承载更多其他功能元件，如碱基编辑、转录调控、多基因编辑等相应元件，这严重限制了其在基因治疗等领域的应用。使用紧凑型Cas蛋白变体的CRISPR-Cas系统可能有助于用AAV产生和传递基因组编辑和调节工具到人类细胞。因此，小型化的CRISPR-Cas系统开发是解决这一技术难题的重要途径，本文主要概括了基于Cas9、Cas12和Cas13蛋白系统在小型化方面的研究进展，包括筛选新型Cas蛋白、缩减蛋白结构域以及引导RNA的改造等，旨在为开发微型精准基因编辑和调控工具提供新思路。目前小型化的CRISPR-Cas系统的局限性主要体现在蛋白分子量的大小和基因编辑的效率、特异性不可兼得上，在未来的研究中若能解决这一问题，获得更小型化的结构域，相信不仅能够优化该系统在体内的传递，更有望为临床带来高效率且低损害的治疗方法。

Abstract

The CRISPR-Cas gene editing technology has revolutionized the fields of biology

medicine

agronomy

etc

. due to its simplicity and efficiency. Laboratory-developed tools

such as the widely recognized CRISPR-

Cas9

have played a pivotal role in addressing a multitude of genetic diseases. By harnessing the targeted nucleic acid capabilities of the CRISPR-Cas system

researchers have successfully integrated various functionalities into Cas proteins

including fluorescent markers

transcriptional regulatory proteins

and base editing components. This has unlocked new possibilities

including chromosome imaging

transcriptional regulation

and precise base editing. Currently

Cas nucleases with large molecular weights

often exceeding 1000 amino acids

are commonly used. However

adeno-associated virus (AAV) vectors

which are extensively employed in gene therapy

have limited capacity to accommodate additional functional components beyond the coding sequences of CRISPR nucleases and guide RNAs (gRNAs). This limitation severely constrains their utilization in gene therapy and other applications. As a result

a significant focus of research has been placed on the miniaturization of CRISPR tools

making them compact enough to align with current delivery methods. Compact Cas protein variants within CRISPR-Cas systems hold the potential to create and deliver genome editing and regulatory tools into human cells using AAV. Hence

the development of miniaturized CRISPR-Cas systems presents a crucial avenue for addressing this technical challenge. This article provides a comprehensive review of research progress in miniaturizing key proteins within two classes of Cas systems: Cas9 and Cas12 for targeting DNA

and Cas13 for targeting RNA. This review encompasses the screening of novel Cas proteins

the reduction of protein structural domains

and the modification of guide RNAs

all with the intention of presenting innovative ideas for the further advancement of compact

precise gene editing

and regulatory tools. The miniaturization of CRISPR-Cas systems is a critical step toward unlocking their full potential in various fields

including biomedicine

agriculture

and basic research. As researchers continue to explore and refine t

hese compact gene editing and regulatory tools

we can expect significant advancement in understanding and manipulating genetic information. This ongoing progress promises to have a profound impact on the future of science and technology. At present

the limitations of the miniaturized CRISPR-Cas system are mainly with the size of protein molecular weight and the efficiency and specificity of gene editing. If we can solve these problems and obtain a smaller structure in future research

not only can we optimize the transmission of the system in the body

but also develop high-efficiency and low-damage treatment methods for clinic applications.

关键词

Keywords

references

MAKAROVA K S , WOLF Y I , IRANZO J , et al . Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants [J ] . Nature Reviews Microbiology , 2020 , 18 ( 2 ): 67 - 83 .

MAKAROVA K S , KOONIN E V . Annotation and classification of CRISPR-Cas systems [J ] . Methods in Molecular Biology , 2015 , 1311 : 47 - 75 .

LI J H , TANG L N , LI T X , et al . Tandem Cas13a/crRNA-mediated CRISPR-FET biosensor: a one-for-all check station for virus without amplification [J ] . ACS Sensors , 2022 , 7 ( 9 ): 2680 - 2690 .

DOETSCHMAN T , GEORGIEVA T . Gene editing with CRISPR/Cas9 RNA-directed nuclease [J ] . Circulation Research , 2017 , 120 ( 5 ): 876 - 894 .

SAFARI F , AFARID M , RASTEGARI B , et al . CRISPR systems: novel approaches for detection and combating COVID-19 [J ] . Virus Research , 2021 , 294 : 198282 .

RAMACHANDRAN A , SANTIAGO J G . CRISPR enzyme kinetics for molecular diagnostics [J ] . Analytical Chemistry , 2021 , 93 ( 20 ): 7456 - 7464 .

FRANGOUL H , ALTSHULER D , CAPPELLINI M D , et al . CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia [J ] . New England Journal of Medicine , 2021 , 384 ( 3 ): 252 - 260 .

FASCHING C L , SERVELLITA V , MCKAY B , et al . COVID-19 variant detection with a high-fidelity CRISPR-Cas12 enzyme [J ] . Journal of Clinical Microbiology , 2022 , 60 ( 7 ): e00261-22 .

GOOTENBERG J S , ABUDAYYEH O O , LEE J W , et al . Nucleic acid detection with CRISPR-Cas13a/C2c2 [J ] . Science , 2017 , 356 ( 6336 ): 438 - 442 .

GUPTA D , BHATTACHARJEE O , MANDAL D , et al . CRISPR-Cas9 system: a new-fangled dawn in gene editing [J ] . Life Sciences , 2019 , 232 : 116636 .

CHEW W L , TABEBORDBAR M , CHENG J K W , et al . A multifunctional AAV-CRISPR-Cas9 and its host response [J ] . Nature Methods , 2016 , 13 ( 10 ): 868 - 874 .

MINGOZZI F , HIGH K A . Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges [J ] . Nature Reviews Genetics , 2011 , 12 ( 5 ): 341 - 355 .

ZINCARELLI C , SOLTYS S , RENGO G , et al . Analysis of AAV serotypes 1–9 mediated gene expression and tropism in mice after systemic injection [J ] . Molecular Therapy , 2008 , 16 ( 6 ): 1073 - 1080 .

KOCH L . CRISPR systems go mini [J ] . Nature Reviews Genetics , 2021 , 22 ( 11 ): 690 .

SHEN B , ZHANG W S , ZHANG J , et al . Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects [J ] . Nature Methods , 2014 , 11 ( 4 ): 399 - 402 .

CHEN S A , LEE B , LEE A Y F , et al . Highly efficient mouse genome editing by CRISPR ribonucleoprotein electroporation of zygotes [J ] . Journal of Biological Chemistry , 2016 , 291 ( 28 ): 14457 - 14467 .

NIOLA F , DAGNÆS-HANSEN F , FRÖDIN M . In vivo editing of the adult mouse liver using CRISPR/Cas9 and hydrodynamic tail vein injection [J ] . Methods in Molecular Biology , 2019 , 1961 : 329 - 341 .

MURUGAN K , BABU K , SUNDARESAN R , et al . The revolution continues: newly discovered systems expand the CRISPR-Cas toolkit [J ] . Molecular Cell , 2017 , 68 ( 1 ): 15 - 25 .

TSUI T K M , LI H . Structure principles of CRISPR-Cas surveillance and effector complexes [J ] . Annual Review of Biophysics , 2015 , 44 : 229 - 255 .

ANDERS C , NIEWOEHNER O , DUERST A , et al . Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease [J ] . Nature , 2014 , 513 : 569 - 573 .

STERNBERG S H , LAFRANCE B , KAPLAN M , et al . Conformational control of DNA target cleavage by CRISPR-Cas9 [J ] . Nature , 2015 , 527 : 110 - 113 .

NISHIMASU H , RAN F A , HSU P D , et al . Crystal structure of Cas9 in complex with guide RNA and target DNA [J ] . Cell , 2014 , 156 ( 5 ): 935 - 949 .

ISHINO Y , KRUPOVIC M , FORTERRE P . History of CRISPR-Cas from encounter with a mysterious repeated sequence to genome editing technology [J ] . Journal of Bacteriology , 2018 , 200 ( 7 ): e00580-17 .

JINEK M , CHYLINSKI K , FONFARA I , et al . A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity [J ] . Science , 2012 , 337 ( 6096 ): 816 - 821 .

HOU Z G , ZHANG Y , PROPSON N E , et al . Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis [J ] . Proceedings of the National Academy of Sciences of the United States of America , 2013 , 110 ( 39 ): 15644 - 15649 .

RAN F A , CONG L , YAN W X , et al . In vivo genome editing using Staphylococcus aureus Cas9 [J ] . Nature , 2015 , 520 ( 7546 ): 186 - 191 .

ZHANG S Q , ZHANG Q , HOU X M , et al . Dynamics of Staphylococcus aureus Cas9 in DNA target association and dissociation [J ] . EMBO Reports , 2020 , 21 ( 10 ): e50184 .

KIM E J , KOO T Y , PARK S W , et al . In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni [J ] . Nature Communications , 2017 , 8 : 14500 .

MA D C , PENG S G , HUANG W R , et al . Rational design of mini-Cas9 for transcriptional activation [J ] . ACS Synthetic Biology , 2018 , 7 ( 4 ): 978 - 985 .

EDRAKI A , MIR A , IBRAHEIM R , et al . A compact, high-accuracy Ca s9 with a dinucleotide PAM for in vivo genome editing [J ] . Molecular Cell , 2019 , 73 ( 4 ): 714 - 726.e4 .

HU Z Y , WANG S , ZHANG C D , et al . A compact Cas9 ortholog from Staphylococcus Auricularis ( Sauri Cas9) expands the DNA targeting scope [J ] . PLoS Biology , 2020 , 18 ( 3 ): e3000686 .

GAO N , ZHANG C D , HU Z Y , et al . Characterization of Brevibacillus laterosporus Cas9 ( Blat Cas9) for mammalian genome editing [J ] . Frontiers in Cell and Developmental Biology , 2020 , 8 : 583164 .

SHAMS A , HIGGINS S A , FELLMANN C , et al . Comprehensive deletion landscape of CRISPR-Cas9 identifies minimal RNA-guided DNA-binding modules [J ] . Nature Communications , 2021 , 12 ( 1 ): 5664 .

WANG S , MAO H L , HOU L H , et al . Compact Sch Cas9 recognizes the simple NNGR PAM [J ] . Advanced Science , 2022 , 9 ( 4 ): e2104789 .

WEI J J , HOU L H , LIU J T , et al . Closely related type Ⅱ-C Cas9 orthologs recognize diverse PAMs [J ] . eLife , 2022 , 11 : e77825 .

SCHULER G , HU C Y , KE A L . Structural basis for RNA-guided DNA cleavage by IscB-ωRNA and mechanistic comparison with Cas9 [J ] . Science , 2022 , 376 ( 6600 ): 1476 - 1481 .

KATO K , OKAZAKI S , KANNAN S , et al . Structure of the IscB-ωRNA ribonucleoprotein complex, the likely ancestor of CRISPR-Cas9 [J ] . Nature Communications , 2022 , 13 ( 1 ): 6719 .

ALTAE-TRAN H , KANNAN S , DEMIRCIOGLU F E , et al . The widespread IS200/IS605 transposon family encodes diverse programmable RNA-guided endonucleases [J ] . Science , 2021 , 374 ( 6563 ): 57 - 65 .

DELTCHEVA E , CHYLINSKI K , SHARMA C M , et al . CRISPR RNA maturation by trans-encoded small RNA and host factor RNase Ⅲ [J ] . Nature , 2011 , 471 ( 7340 ): 602 - 607 .

MALI P , YANG L H , ESVELT K M , et al . RNA-guided human genome engineering via Cas9 [J ] . Science , 2013 , 339 ( 6121 ): 823 - 826 .

ZHANG Y P , WANG J , WANG Z B , et al . A gRNA-tRNA array for CRISPR-Cas9 based rapid multiplexed genome editing in Saccharomyces cerevisiae [J ] . Nature Communications , 2019 , 10 ( 1 ): 1053 .

MEFFERD A L , KORNEPATI A V R , BOGERD H P , et al . Expression of CRISPR/Cas single guide RNAs using small tRNA promoters [J ] . RNA , 2015 , 21 ( 9 ): 1683 - 1689 .

FONFARA I , RICHTER H , BRATOVIČ M , et al . The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA [J ] . Nature , 2016 , 532 ( 7600 ): 517 - 521 .

ZETSCHE B , GOOTENBERG J S , ABUDAYYEH O O , et al . Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system [J ] . Cell , 2015 , 163 ( 3 ): 759 - 771 .

DONG D , REN K , QIU X L , et al . The crystal structure of Cpf1 in complex with CRISPR RNA [J ] . Nature , 2016 , 532 ( 7600 ): 522 - 526 .

GAO P , YANG H , RAJASHANKAR K R , et al . Type Ⅴ CRISPR-Cas Cpf1 endonuclease employs a unique mechanism for crRNA-mediated target DNA recognition [J ] . Cell Research , 2016 , 26 ( 8 ): 901 - 913 .

BURSTEIN D , HARRINGTON L B , STRUTT S C , et al . New CRISPR–Cas systems from uncultivated microbes [J ] . Nature , 2017 , 542 ( 7640 ): 237 - 241 .

LIU J J , ORLOVA N , OAKES B L , et al . CasX enzymes comprise a distinct family of RNA-guided genome editors [J ] . Nature , 2019 , 566 ( 7743 ): 218 - 223 .

TU M J , LIN L , CHENG Y L , et al . A ‘new lease of life’: Fn Cpf1 possesses DNA cleavage activity for genome editing in human cells [J ] . Nucleic Acids Research , 2017 , 45 ( 19 ): 11295 - 11304 .

TENG F , CUI T T , FENG G H , et al . Repurposing CRISPR-Cas12b for mammalian genome engineering [J ] . Cell Discovery , 2018 , 4 : 63 .

YAN W X , HUNNEWELL P , ALFONSE L E , et al . Functionally diverse type Ⅴ CRISPR-Cas systems [J ] . Science , 2019 , 363 ( 6422 ): 88 - 91 .

HUANG C J , ADLER B A , DOUDNA J A . A naturally DNase-free CRISPR-Cas12c enzyme silences gene expression [J ] . Molecular Cell , 2022 , 82 ( 11 ): 2148 - 2160.e4 .

WANG Y , QI T , LIU J T , et al . A highly specific CRISPR-Cas12j nuclease enables allele-specific genome editing [J ] . Science Advances , 2023 , 9 ( 6 ): eabo6405 .

PAUSCH P , AL-SHAYEB B , BISOM-RAPP E , et al . CRISPR-Cas φ from huge phages is a hypercompact genome editor [J ] . Science , 2020 , 369 ( 6501 ): 333 - 337 .

XU X S , CHEMPARATHY A , ZENG L P , et al . Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing [J ] . Molecular Cell , 2021 , 81 ( 20 ): 4333 - 4345.e4 .

HARRINGTON L B , BURSTEIN D , CHEN J S , et al . Programmed DNA destruction by miniature CRISPR-Cas14 enzymes [J ] . Science , 2018 , 362 ( 6416 ): 839 - 842 .

KARVELIS T , BIGELYTE G , YOUNG J K , et al . PAM recognition by miniature CRISPR-Cas12f nucleases triggers programmable double-stranded DNA target cleavage [J ] . Nucleic Acids Research , 2020 , 48 ( 9 ): 5016 - 5023 .

TAKEDA S N , NAKAGAWA R , OKAZAKI S , et al . Structure of the miniature type Ⅴ-F CRISPR-Cas effector enzyme [J ] . Molecular Cell , 2021 , 81 ( 3 ): 558 - 570.e3 .

ANZALONE A V , KOBLAN L W , LIU D R . Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors [J ] . Nature Biotechnology , 2020 , 38 ( 7 ): 824 - 844 .

KIM D Y , LEE J M , MOON S B , et al . Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus [J ] . Nature Biotechnology , 2022 , 40 ( 1 ): 94 - 102 .

WU Z W , ZHANG Y F , YU H P , et al . Programmed genome editing by a miniature CRISPR-Cas12f nuclease [J ] . Nature Chemical Biology , 2021 , 17 ( 11 ): 1132 - 1138 .

HUANG H X , LV W Q , LI J H , et al . Comparison of DNA targeting CRISPR editors in human cells [J ] . Cell & Bioscience , 2023 , 13 ( 1 ): 11 .

KARVELIS T , DRUTEIKA G , BIGELYTE G , et al . Transposon-associated TnpB is a programmable RNA-guided DNA endonuclease [J ] . Nature , 2021 , 599 ( 7886 ): 692 - 696 .

XIANG G H , LI Y Q , SUN J , et al . Evolutionary mining and functional characterization of TnpB nucleases identify efficient miniature genome editors [J ] . Nature Biotechnology , 2024 , 42 : 745 - 757 .

CHEN W Z , MA J C , WU Z W , et al . Cas12n nucleases, early evolutionary intermediates of type Ⅴ CRISPR, comprise a distinct family of miniature genome editors [J ] . Molecular Cell , 2023 , 83 ( 15 ): 2768 - 2780.e6 .

SHMAKOV S , SMARGON A , SCOTT D , et al . Diversity and evolution of class 2 CRISPR-Cas systems [J ] . Nature Reviews Microbiology , 2017 , 15 ( 3 ): 169 - 182 .

SASNAUSKAS G , TAMULAITIENE G , DRUTEIKA G , et al . TnpB structure reveals minimal functional core of Cas12 nuclease family [J ] . Nature , 2023 , 616 ( 7956 ): 384 - 389 .

SENTHILNATHAN R , ILANGOVAN I , KUNALE M , et al . An update on CRISPR-Cas12 as a versatile tool in genome editing [J ] . Molecular Biology Reports , 2023 , 50 ( 3 ): 2865 - 2881 .

ABUDAYYEH O O , GOOTENBERG J S , ESSLETZBICHLER P , et al . RNA targeting with CRISPR-Cas13 [J ] . Nature , 2017 , 550 ( 7675 ): 280 - 284 .

KONERMANN S , LOTFY P , BRIDEAU N J , et al . Transcriptome engineering with RNA-targeting type Ⅵ-D CRISPR effectors [J ] . Cell , 2018 , 173 ( 3 ): 665 - 676.e14 .

HU Y P , CHEN Y C , XU J , et al . Metagenomic discovery of novel CRISPR-Cas13 systems [J ] . Cell Discovery , 2022 , 8 ( 1 ): 107 .

LIU L , LI X Y , WANG J Y , et al . Two distant catalytic sites are responsible for C2c2 RNase activities [J ] . Cell , 2017 , 168 ( 1-2 ): 121 - 134 .e12.

WU S M , TIAN P F , TAN T W . CRISPR-Cas13 technology portfolio and alliance with other genetic tools [J ] . Biotechnology Advances , 2022 , 61 : 108047 .

SHMAKOV S , ABUDAYYEH O O , MAKAROVA K S , et al . Discovery and functional characterization of diverse class 2 CRISPR-Cas systems [J ] . Molecular Cell , 2015 , 60 ( 3 ): 385 - 397 .

SMARGON A A , COX D B T , PYZOCHA N K , et al . Cas13b is a type Ⅵ-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28 [J ] . Molecular Cell , 2017 , 65 ( 4 ): 618 - 630.e7 .

YAN W X , CHONG S R , ZHANG H B , et al . Cas13d is a compact RNA-targeting type Ⅵ CRISPR effector positively modulated by a WYL-domain-containing accessory protein [J ] . Molecular Cell , 2018 , 70 ( 2 ): 327 - 339.e5 .

XU C L , ZHOU Y S , XIAO Q Q , et al . Programmable RNA editing with compact CRISPR-Cas13 systems from uncultivated microbes [J ] . Nature Methods , 2021 , 18 ( 5 ): 499 - 506 .

KANNAN S , ALTAE-TRAN H , JIN X , et al . Compact RNA editors with small Cas13 proteins [J ] . Nature Biotechnology , 2022 , 40 ( 2 ): 194 - 197 .

TANG T , HAN Y L , WANG Y R , et al . Programmable system of Cas13-mediated RNA modification and its biological and biomedical applications [J ] . Frontiers in Cell and Developmental Biology , 2021 , 9 : 677587 .

WANG F , WANG L R , ZOU X , et al . Advances in CRISPR-Cas systems for RNA targeting, tracking and editing [J ] . Biotechnology Advances , 2019 , 37 ( 5 ): 708 - 729 .

ZHAO F Y , ZHANG T , SUN X D , et al . A strategy for Cas13 miniaturization based on the structure and AlphaFold [J ] . Nature Communications , 2023 , 14 ( 1 ): 5545 .

BANDARU S , TSUJI M H , SHIMIZU Y , et al . Structure-based design of gRNA for Cas13 [J ] . Scientific Reports , 2020 , 10 ( 1 ): 11610 .

XIAO Q Q , XU Z J , XUE Y Y , et al . Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor [J ] . Science Translational Medicine , 2022 , 14 ( 654 ): eabn0449 .

GAO S Q , WANG Y , QI T , et al . Genome editing with natural and engineered Cj Cas9 orthologs [J ] . Molecular Therapy , 2023 , 31 ( 4 ): 1177 - 1187 .

ZHOU F X , YU X R , GAN R , et al . CRISPRimmunity: an interactive web server for CRISPR-associated Important Molecular events and Modulators Used in geNome edIting Tool identifYing [J ] . Nucleic Acids Research , 2023 , 51 ( W1 ): W93 - W107 .

AWAN M J A , AMIN I , MANSOOR S . Mini CRISPR-Cas12f1: a new genome editing tool [J ] . Trends in Plant Science , 2022 , 27 ( 2 ): 110 - 112 .

CHO E Y , RYU J Y , LEE H A R , et al . Lecithin nano-liposomal particle as a CRISPR/Cas9 complex delivery system for treating type 2 diabetes [J ] . Journal of Nanobiotechnology , 2019 , 17 ( 1 ): 19 .

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

合成生物学在疾病信息记录与实时监测中的应用潜力